WAM
AGN

Wolverine Asset Management’s Allergan plc AGN Stock Holding History

Wolverine Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-109,200
Closed -$17.9M – 1794
2017
Q4 		$17.9M Sell
109,200
-700
-0.6% -$126K 0.18% 109
2017
Q3 		$22.5M Sell
109,900
-16,000
-13% -$3.72M 0.25% 70
2017
Q2 		$30.6M Buy
125,900
+8,500
+7% +$2M 0.39% 53
2017
Q1 		$28M Buy
117,400
+60,000
+105% +$14M 0.44% 48
2016
Q4 		$12.1M Sell
57,400
-26,600
-32% -$5.51M 0.16% 128
2016
Q3 		$19.3M Buy
84,000
+83,900
+83,900% +$20.5M 0.29% 85
2016
Q2 		$23K Buy
+100
New +$23.1K ﹤0.01% 1091
2016
Q1 		– Sell
-10
Closed -$19K – 1745
2015
Q4 		$19K Buy
+10
New +$2.98K ﹤0.01% 1334

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Wolverine Asset Management's AGN Position: Q2 2020 in Review

Wolverine Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 44,667 shares — an estimated $7.91M sold.

Wolverine Asset Management first reported a position in AGN in Q1 2016 and held it in 8 quarters. The position peaked at $7.91M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wolverine Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 44,667 Allergan plc shares in Q2 2020, an estimated $7.91M.
  • Wolverine Asset Management first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
  • Wolverine Asset Management's Allergan plc position peaked at $7.91M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wolverine Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.